Skip to main content
Modules/Regulatory Affairs/Summary of Safety and Clinical Performance (SSCP)
Regulatory Affairs

Summary of Safety and Clinical Performance (SSCP)

Author and maintain the Summary of Safety and Clinical Performance for implantable and class III devices, as required by EU MDR Article 32, linked to the product record.

Key Capabilities

What you get with the Summary of Safety and Clinical Performance (SSCP) module.

Intended purpose written in lay language, with indications, contraindications, and warnings
Clinical benefits summary and residual risks summary
Performance summary with key performance indicators and test results
Clinical evidence summary, including clinical study and literature references and PMCF data
Document version and version date recorded, with the implant card reference where one exists

How It Connects

Summary of Safety and Clinical Performance (SSCP) doesn't work in isolation. It connects seamlessly with other modules in MoniDoseQMS for full traceability across your quality system.

Ready to see Summary of Safety and Clinical Performance (SSCP) in action?

Book a 30-minute demo tailored to your regulatory needs. Our team will walk you through how Summary of Safety and Clinical Performance (SSCP) works within your specific compliance context.

More in Regulatory Affairs

Explore other modules in the Regulatory Affairs category.